viruses Article Isolation and Characterization of Clinical RSV Isolates in Belgium during the Winters of 2016–2018 Winke Van der Gucht 1, Kim Stobbelaar 1,2, Matthias Govaerts 1 , Thomas Mangodt 2, Cyril Barbezange 3 , Annelies Leemans 1, Benedicte De Winter 4, Steven Van Gucht 3 , Guy Caljon 1, Louis Maes 1 , Jozef De Dooy 4,5, Philippe Jorens 4,5, Annemieke Smet 4 , Paul Cos 1, Stijn Verhulst 2,4 and Peter L. Delputte 1,* 1 Laboratory of Microbiology, Parasitology and Hygiene, and Infla-Med Centre of Excellence, University of Antwerp (UA), Universiteitsplein 1 S.7, 2610 Antwerp, Belgium;
[email protected] (W.V.d.G.);
[email protected] (K.S.);
[email protected] (M.G.);
[email protected] (A.L.);
[email protected] (G.C.);
[email protected] (L.M.);
[email protected] (P.C.) 2 Pediatrics Department, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium;
[email protected] (T.M.);
[email protected] (S.V.) 3 Sciensano, Rue Juliette Wytsmanstraat 14, 1050 Brussels, Belgium;
[email protected] (C.B.);
[email protected] (S.V.G.) 4 Laboratory of Experimental Medicine and Pediatrics, University of Antwerp (UA), Univeristeitsplein 1 T.3, 2610 Antwerp, Belgium;
[email protected] (B.D.W.);
[email protected] (J.D.D.);
[email protected] (P.J.);
[email protected] (A.S.) 5 Pediatric intensive care unit, Antwerp University Hospital (UZA), Wilrijkstraat 10, 2650 Edegem, Belgium * Correspondence:
[email protected]; Tel.: +32-3-265-26-25 Received: 29 July 2019; Accepted: 4 November 2019; Published: 6 November 2019 Abstract: Respiratory Syncytial Virus (RSV) is a very important viral pathogen in children, immunocompromised and cardiopulmonary diseased patients and the elderly.